跳至主要内容
临床试验/NCT07603154
NCT07603154Enrolling By Invitation不适用

Clinical Efficacy Observation Project of Peng's "Fenjin Tuina" in Treating Superior Cluneal Nerve Entrapment Syndrome

Guangzhou University of Chinese Medicine1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2026年4月23日最近更新:

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
70
试验地点
1

研究概览

简要总结

The goal of this clinical trial is to learn if Peng's "Fenjin Tuina" works to treat superior cluneal nerve entrapment syndrome in adults. It will also learn about the safety of Peng's "Fenjin Tuina". The main questions it aims to answer are:Did Peng's "Fenjin Tuina" therapy improve the pain symptoms of participants; Will participants experience health problems using Peng's "Fenjin Tuina" therapy;Researchers will compare Peng's "Fenjin Tuina" with conventional massage therapy to see if Peng's "segmented massage" can treat superior cluneal nerve entrapment syndrome.Participants will visit the clinic once a week for checkups and treatments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1. Those meeting the diagnostic criteria for superior cluneal nerve entrapment syndrome as described in "Perineal Nerve Entrapment Syndrome";
  • Age ranging from 18 to 70 years (inclusive of 18 and 70), gender not limited;
  • Good compliance and able to undergo massage therapy;
  • Capable of understanding the contents of the scale and questionnaire, and willing to participate in this clinical study and sign the informed consent form.

排除标准

  • 1. Other patients not meeting the diagnostic criteria for superior cluneal nerve entrapment syndrome;
  • Those with large areas of skin damage on the lumbar region and the posterior lateral part of the thigh;
  • Those who have received other related treatments and may affect the observation indicators of this study;
  • Those who cannot be evaluated for efficacy, such as those who cannot understand the contents of the scale;
  • Nursing mothers or pregnant women or those preparing for pregnancy;
  • Those with severe life-threatening primary diseases such as cardiovascular, liver, kidney and hematopoietic system diseases, as well as patients with mental illness or those with legally infectious diseases;
  • Those diagnosed with progressive malignant tumors or other serious consuming diseases prone to or with infectious diseases such as infections and bleeding;
  • Those with severe osteoporosis or tumor bone metastasis;
  • Those taking anticoagulant or antithrombotic drugs;
  • Those who voluntarily give up or cannot cooperate with treatment, observation or examination for various reasons.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hongyi Chen

Resident physician

Guangzhou University of Chinese Medicine

研究点 (1)

Loading locations...

相似试验